H D Humes

 H D. Humes
Professor Emeritus of Internal Medicine
Medical School
Email:
[email protected]
Available to mentor
H D Humes
H D. Humes
Professor Emeritus/a
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Weil Institute for Critical Care Research
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      Center for Global Health Equity

    Recent Publications

     See All Publications
    • Journal Article
      Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy
      Goldstein SL, Krallman KA, Harris M, Basu RK, Askenazi DJ, Menon S, Zinter MS, Gorga SM, Humes HD, Scribe EC, Catanzaro DA, Iyer SPN, Chung KK. Pediatric Nephrology, 2026 Jan 1; DOI:10.1007/s00467-026-07181-1
      PMID: 41652244
    • Journal Article
      Projected hospitalization cost impact of the selective cytopheretic device in pediatric acute kidney injury.
      Humes HD, Kleinman N, Kammerer J, Iyer SPN, Goldstein SL, Kleinman A, Chung KK, Thakar CV. J Med Econ, 2025 Dec; 28 (1): 1467 - 1475. DOI:10.1080/13696998.2025.2550860
      PMID: 40847756
    • Preprint
      Early Post-Approval Experience of The Selective Cytopheretic Device Surveillance Registry for Pediatric AKI Requiring Kidney Replacement Therapy
      Goldstein SL, Krallman K, Harris M, Basu R, Askenazi D, Menon S, Zinter M, Gorga S, Humes HD, Scribe E, Catanzaro DA, Iyer SPN, Chung K. 2025 Nov 21; Research Square, DOI:10.21203/rs.3.rs-7988526/v1
    • Journal Article
      Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts.
      Stanski NL, Seo J, Jenkins T, Krallman KA, Menon S, Humes HD, Askenazi DJ, Basu RK, Akcan Arikan A, Goldstein SL, Gist KM, WE-ROCK Investigators . Blood Purif, 2025 Oct 23; 1 - 11. DOI:10.1159/000549111
      PMID: 41129413
    • Preprint
      Immunomodulatory Effects of a Cell Processing Device: Insights from Single Cell RNA Sequencing and Gene Set Enrichment Analysis
      Pino CJ, Odum J, Medendorp T, Humes HD. 2025 Oct 11; bioRxiv, DOI:10.1101/2025.10.03.680363
    • Journal Article
      Regional citrate anticoagulation and Infectious complications in critically ill children and young adults receiving continuous renal replacement therapy.
      Gist KM, Iyer SPN, Humes HD, Goldstein SL, Damian M, Cappoli A, Joseph C, Soranno DE, Starr M, Tolwani A, Chung KK, Mottes T, Zang H, Seo J, Ollberding NJ, Menon S, WE-ROCK Investigators . Nephron, 2025 Sep 15; 1 - 26. DOI:10.1159/000548253
      PMID: 40952919
    • Journal Article
      Selective Cytopheretic Device Therapy in the Context of Extracorporeal Membrane Oxygenation
      Szamosfalvi M, Pino CJ, Humes HD. Medicina, 2025 Aug 27; 61 (9): 1513 DOI:10.3390/medicina61091513
    • Preprint
      Management Dilemma in Choosing Evolving Treatments in Neutropenic Septic Shock
      Humes HD, Luckritz K, Gorga S, Plomaritas K, Hoatlin S, Humes M, Yessayan L. 2025 Mar 16; Research Square, DOI:10.21203/rs.3.rs-6221280/v1

    Featured News & Stories

         H. David Humes, MD
    Medical School News

    H. David Humes, MD, named 2026 Distinguished University Innovator of the Year

    H. David Humes, MD, is being awarded this year’s Distinguished University Innovator of the Year. The award is the highest honor for U-M faculty members who have developed transformative ideas, processes or technologies and shepherded them to market for broad societal impact.
         man showing device in his hand smiling with blue gloves on
    Health Lab

    First-of-its-kind therapeutic device saves child in septic shock with multiorgan failure

    The selective cytopheretic device, created by scientists and doctors at Michigan Medicine, is a first-in-class autologous immune cell directed therapy and successfully treated a young patient in septic shock and multiorgan failure.